SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, announced today it will release fourth quarter and full year 2023 results after the market closes on Monday, March 18, 2024. Following the release, management will host a conference call and audio webcast to review results and provide a brief business and outlook update that same day at 1:30 p.m. PT / 4:30 p.m. ET. Live c ...

Key PointsAugmedix uses ambient AI to transform doctor-patient conversations into structured medical notes, helping to improve workflows, reduce administrative burdens, and improve the accuracy of medical records.HCA Healthcare, the nation's largest for-profit hospital system, is a client and investor in Augmedix.Augmedix seeks to evolve the technology to serve as a change agent for organizations.5 stocks we like better than AugmedixAugmedix Inc. NASDAQ: AUGX is an artificial intelligence (AI) powered ambie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-40890 AUGMEDIX, INC. (Exact name of registrant as specified in its charter) | --- | --- | |---------------- ...

Augmedix, Inc. (NASDAQ:AUGX) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haasec - William Blair Neil Chatterji - B. Riley Securities Allen Klee - Maxim Group LLC Aaron Wukmir - Lake Street Capital Markets Bill Sutherland - The Benchmark Company Pat Walravens - JMP Operator Greetings and welcome to Augmedix, Inc. 2023 Third Quarter Earnings Conference Call. [Operator Instructio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Delaware 83-3299164 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 111 Sutter Street, Suite 1300, San Francisco, California 94104 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (888) 669-4885 Title of each class Trading Symbol (s) Name on each exchange on which registered Common Stock, $0.0001 par value per share AUGX The Nasdaq ...

Augmedix, Inc. (NASDAQ:AUGX) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matt Chesler - IR Manny Krakaris - CEO Paul Ginocchio - CFO Conference Call Participants Jared Haasec - William Blair Neil Chatterji - B. Riley Securities Aaron Wukmir - Lake Street Capital Markets Allen Klee - Maxim Group LLC Operator Ladies and gentlemen, greetings, and welcome to the Augmedix Inc. Second Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mod ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-40890 | --- | --- | |----------------------------------------------------------------------------|------------- ...

Investor Presentation May 2023 ...

Augmedix, Inc. (NASDAQ:AUGX) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ET Company Participants Matt Chesler - Investor Relations Manny Krakaris - Chief Executive Officer Paul Ginocchio - Chief Financial Officer Conference Call Participants Jared Haase - William Blair & Company LLC Brooks O'Neil - Lake Street Capital Markets Allen Klee - Maxim Group Neil Chatterji - B. Riley Securities Operator Greetings, and welcome to the Augmedix Inc. First Quarter 2023 Earnings Conference Call. At this time, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share AUGX The Nasdaq Stock Market LLC FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Comm ...